Coghlin J, Gann P H, Hammond S K, Skipper P L, Taghizadeh K, Paul M, Tannenbaum S R
Department of Family and Community Medicine, University of Massachusetts Medical Center, Worcester 01655.
J Natl Cancer Inst. 1991 Feb 20;83(4):274-80. doi: 10.1093/jnci/83.4.274.
Maternal-fetal exchange of a potent tobacco-related human carcinogen, 4-aminobiphenyl, was studied in smoking (n = 14) and nonsmoking (n = 38) pregnant women. N-Hydroxy-4-aminobiphenyl, the active metabolite of 4-aminobiphenyl, forms chemical addition products (adducts) with hemoglobin. Levels of 4-aminobiphenyl hemoglobin adducts were measured in maternal-fetal paired blood samples obtained from smoking and nonsmoking women during labor and delivery. Carcinogen-hemoglobin adducts were detected in all maternal and fetal blood samples. Levels of such adducts were significantly higher (P less than .001) in maternal and fetal blood samples from smokers: the mean 4-aminobiphenyl hemoglobin adduct level was 92 +/- 54 pg/g of hemoglobin in blood samples from fetuses of smokers, and 17 +/- 13 pg/g of hemoglobin in blood samples from fetuses of nonsmokers; the mean maternal 4-aminobiphenyl hemoglobin adduct level was 183 +/- 108 pg/g of hemoglobin in smokers, and 22 +/- 8 pg/g of hemoglobin in nonsmokers. Fetal carcinogen-adduct levels were consistently lower than maternal levels: the mean maternal to fetal ratio was 2.4 +/- 1.1 in smokers and 1.9 +/- .98 in nonsmokers. Fetal 4-aminobiphenyl hemoglobin adduct levels were strongly associated (correlation coefficient [r2] = .51, P = .002) with maternal 4-aminobiphenyl hemoglobin adduct levels when paired samples from smoking mothers were analyzed. A measure of third-trimester tobacco smoke exposure based on number of cigarettes smoked per day, amount of each cigarette smoked, and depth of inhalation was associated (r2 = .59, P = .029) with maternal 4-aminobiphenyl levels but not with fetal 4-aminobiphenyl levels. This study demonstrates that a potent tobacco-related carcinogen, 4-aminobiphenyl, or its active metabolite, N-hydroxy-4-aminobiphenyl, crosses the human placenta and binds to fetal hemoglobin in concentrations that are significantly higher in smokers than in nonsmokers.
在吸烟(n = 14)和不吸烟(n = 38)的孕妇中,研究了一种与烟草相关的强效人类致癌物4-氨基联苯在母婴之间的交换情况。4-氨基联苯的活性代谢产物N-羟基-4-氨基联苯会与血红蛋白形成化学加成产物(加合物)。在分娩时从吸烟和不吸烟女性中获取的母婴配对血样中,检测了4-氨基联苯血红蛋白加合物的水平。在所有母婴血样中均检测到致癌物-血红蛋白加合物。吸烟者母婴血样中的此类加合物水平显著更高(P <.001):吸烟孕妇胎儿血样中4-氨基联苯血红蛋白加合物的平均水平为92±54 pg/g血红蛋白,不吸烟孕妇胎儿血样中为17±13 pg/g血红蛋白;吸烟孕妇母体4-氨基联苯血红蛋白加合物的平均水平为183±108 pg/g血红蛋白,不吸烟孕妇为22±8 pg/g血红蛋白。胎儿致癌物加合物水平始终低于母体水平:吸烟者母体与胎儿的平均比值为2.4±1.1,不吸烟者为1.9±.98。对吸烟母亲的配对样本进行分析时,胎儿4-氨基联苯血红蛋白加合物水平与母体4-氨基联苯血红蛋白加合物水平密切相关(相关系数[r2]=.51,P =.002)。基于每日吸烟量、每支烟的吸食量和吸入深度的孕晚期烟草烟雾暴露量与母体4-氨基联苯水平相关(r2 =.59,P =.029),但与胎儿4-氨基联苯水平无关。这项研究表明,一种与烟草相关的强效致癌物4-氨基联苯或其活性代谢产物N-羟基-4-氨基联苯可穿过人类胎盘,并与胎儿血红蛋白结合,其在吸烟者中的浓度显著高于不吸烟者。